Prot #NU 19H05: Phase 1 trial of Ivosidenib and FLAG Chemotherapy in Relapsed/Refractory IDH1+ Acute Myeloid Leukemia (AML)

Project: Research project

Project Details

StatusActive
Effective start/end date2/5/20 → 12/15/26

Funding

  • Agios Pharmaceuticals, Inc. ((OE) Prot #NU 19H05)